In a report released on August 25, Jailendra Singh from Truist Financial maintained a Hold rating on Cano Health (CANO – Research Report). The company’s shares closed yesterday at $0.31.
Singh covers the Healthcare sector, focusing on stocks such as Agilon Health, Evolent Health, and Cano Health. According to TipRanks, Singh has an average return of -12.9% and a 32.65% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Cano Health with a $0.86 average price target, representing a 173.10% upside. In a report released on August 15, TD Cowen also maintained a Hold rating on the stock with a $0.50 price target.
See Insiders’ Hot Stocks on TipRanks >>
CANO market cap is currently $157.3M and has a P/E ratio of -0.20.
Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CANO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Jaws Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Read More on CANO:
